Progress in the Research of Atherosclerosis and Restenosis Using an in vitro Method: Transfilter Cocultures with Human Vascular Cells.

再狭窄 体外 血管平滑肌 体内 血管成形术 气球 医学 平滑肌 生物 病理 药理学 支架 内科学 生物技术 生物化学
作者
Siegel-Axel Di,R Viehban,Betz El,Karsch Kr
出处
期刊:PubMed 卷期号:16 (3): 117-117 被引量:2
链接
标识
摘要

Excessive proliferation and migration of human arterial smooth muscle cells (haSMC) are prominent features of both primary atherogenesis, as well as restenosis following interventions, such as balloon angioplasty (PTCA) or stent implantation. Thus, in the last two decades many efforts are made to establish a therapeutic strategy with antiproliferative and antimigratory compounds. A great variety of substances belonging to different drug classes were already tested both in vitro and in vivo but there is still no breakthrough in the prevention or treatment of human arterial vessel diseases. Among the choice of more potent compounds, the main reasons for this failure are the use of unappropriate animal models or animal cell cultures allowing no direct transfer of the results to the human situation. For that reason, the more complex transfilter coculture model was developed and established for the cocultivation of human vascular cells and blood cells to imitate the morphology of the arterial vessel wall in vitro. The present paper describes the morphology of fibromuscular-like and atheromatous-like proliferates induced in this model in comparison to human plaques, as well as its practicability for the pre-screening of antiarteriosclerotic compounds. As examples, two chemically different compounds are shown. We found that the described transfilter coculture system is a suitable and well-established model allowing fast and reproducible studies with antiproliferative and antimigratory drugs. The transferral of the results to the human situation on the basis of these complex in vitro-studies seems to be improved when compared to most animal models.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
全叔发布了新的文献求助10
1秒前
szmsnail完成签到,获得积分10
1秒前
共享精神应助高挑的灭绝采纳,获得10
2秒前
大个应助可乐采纳,获得10
2秒前
zzzz发布了新的文献求助10
2秒前
MA完成签到,获得积分20
2秒前
李爱国应助Xueanliu采纳,获得10
3秒前
kkkkkk发布了新的文献求助10
3秒前
酸酸关注了科研通微信公众号
3秒前
3秒前
郭mm发布了新的文献求助10
3秒前
小蔡发布了新的文献求助10
3秒前
传奇3应助科研通管家采纳,获得10
4秒前
LILING发布了新的文献求助10
4秒前
雨碎寒江发布了新的文献求助10
4秒前
乐乐应助科研通管家采纳,获得10
4秒前
4秒前
小马甲应助科研通管家采纳,获得10
4秒前
4秒前
星辰大海应助科研通管家采纳,获得10
4秒前
hw完成签到 ,获得积分10
4秒前
4秒前
打打应助科研通管家采纳,获得10
4秒前
麦子应助科研通管家采纳,获得10
4秒前
传奇3应助科研通管家采纳,获得10
4秒前
上官若男应助科研通管家采纳,获得10
5秒前
wanci应助科研通管家采纳,获得10
5秒前
wanci应助科研通管家采纳,获得10
5秒前
FashionBoy应助科研通管家采纳,获得10
5秒前
明亮天抒发布了新的文献求助10
5秒前
MW发布了新的文献求助10
5秒前
传奇3应助科研通管家采纳,获得10
5秒前
斯文败类应助科研通管家采纳,获得10
5秒前
BowieHuang应助科研通管家采纳,获得10
5秒前
NexusExplorer应助科研通管家采纳,获得10
5秒前
Mini33应助科研通管家采纳,获得10
5秒前
Ava应助科研通管家采纳,获得10
5秒前
qqwrv发布了新的文献求助10
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Principles of town planning : translating concepts to applications 500
Modified letrozole versus GnRH antagonist protocols in ovarian aging women for IVF: An Open-Label, Multicenter, Randomized Controlled Trial 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6062899
求助须知:如何正确求助?哪些是违规求助? 7895196
关于积分的说明 16312582
捐赠科研通 5206119
什么是DOI,文献DOI怎么找? 2785229
邀请新用户注册赠送积分活动 1767884
关于科研通互助平台的介绍 1647451